Finally selling this giant debt ridden fecalith

See the below story in laboratory economics. Aurora will not exist in 10 months.

Aurora Diagnostics (Palm Beach Gardens, FL) has hired the investment bank Moelis & Com-
pany (New York City) to help locate a potential buyer of the pathology practice management
company, several sources tell Laboratory Economics.
Aurora’s largest shareholders include Summit Partners (51% stake) and KRG Capital (35% stake)
and former Chairman and CEO James New (5% stake).
Since being founded in 2006 by James New and other former executives from AmeriPath,Aurora has acquired 32 pathology practices with more than 220 pathologists and annual revenue
of roughly $300 million.
However, Aurora borrowed heavily to make these acquisitions. The company owes more than
$220 million to Cerberus Business Finance (New York City) that is secured by essentially all of
Aurora’s assets and acquired subsidiaries. This debt comes due on July 14, 2019.
In addition, Aurora has another $200 million of unsecured debt that comes due January 15, 2020.
Aurora’s total debt of $420+ million requires interest payments of more than $40 million per year
and limits the company’s options.
 


















See the below story in laboratory economics. Aurora will not exist in 10 months.

Aurora Diagnostics (Palm Beach Gardens, FL) has hired the investment bank Moelis & Com-
pany (New York City) to help locate a potential buyer of the pathology practice management
company, several sources tell Laboratory Economics.
Aurora’s largest shareholders include Summit Partners (51% stake) and KRG Capital (35% stake)
and former Chairman and CEO James New (5% stake).
Since being founded in 2006 by James New and other former executives from AmeriPath,Aurora has acquired 32 pathology practices with more than 220 pathologists and annual revenue
of roughly $300 million.
However, Aurora borrowed heavily to make these acquisitions. The company owes more than
$220 million to Cerberus Business Finance (New York City) that is secured by essentially all of
Aurora’s assets and acquired subsidiaries. This debt comes due on July 14, 2019.
In addition, Aurora has another $200 million of unsecured debt that comes due January 15, 2020.
Aurora’s total debt of $420+ million requires interest payments of more than $40 million per year
and limits the company’s options.
 






See the below story in laboratory economics. Aurora will not exist in 10 months.

Aurora Diagnostics (Palm Beach Gardens, FL) has hired the investment bank Moelis & Com-
pany (New York City) to help locate a potential buyer of the pathology practice management
company, several sources tell Laboratory Economics.
Aurora’s largest shareholders include Summit Partners (51% stake) and KRG Capital (35% stake)
and former Chairman and CEO James New (5% stake).
Since being founded in 2006 by James New and other former executives from AmeriPath,Aurora has acquired 32 pathology practices with more than 220 pathologists and annual revenue
of roughly $300 million.
However, Aurora borrowed heavily to make these acquisitions. The company owes more than
$220 million to Cerberus Business Finance (New York City) that is secured by essentially all of
Aurora’s assets and acquired subsidiaries. This debt comes due on July 14, 2019.
In addition, Aurora has another $200 million of unsecured debt that comes due January 15, 2020.
Aurora’s total debt of $420+ million requires interest payments of more than $40 million per year
and limits the company’s options.
 






See the below story in laboratory economics. Aurora will not exist in 10 months.

Aurora Diagnostics (Palm Beach Gardens, FL) has hired the investment bank Moelis & Com-
pany (New York City) to help locate a potential buyer of the pathology practice management
company, several sources tell Laboratory Economics.
Aurora’s largest shareholders include Summit Partners (51% stake) and KRG Capital (35% stake)
and former Chairman and CEO James New (5% stake).
Since being founded in 2006 by James New and other former executives from AmeriPath,Aurora has acquired 32 pathology practices with more than 220 pathologists and annual revenue
of roughly $300 million.
However, Aurora borrowed heavily to make these acquisitions. The company owes more than
$220 million to Cerberus Business Finance (New York City) that is secured by essentially all of
Aurora’s assets and acquired subsidiaries. This debt comes due on July 14, 2019.
In addition, Aurora has another $200 million of unsecured debt that comes due January 15, 2020.
Aurora’s total debt of $420+ million requires interest payments of more than $40 million per year
and limits the company’s options.
 






























I'm not sure if the original poster coined the term "fecalith", but if so I send my regards. This is the first time I have have heard the term, but it is a good one and should be included in all dictionaries.
 






dd will sink the titanic unless the iceberg gets it first. or was it the SS minnow?

S. S. Minnow. The S. S. Minnow was a charter boat that ran aground on the shore of an uncharted desert isle (in the south Pacific Ocean
Pacific Ocean
th


The Pacific Ocean is the largest and deepest of Earth's oceanic divisions.
 










































Perhaps someone could explain why anyone would want to buy a company over $500,000,000 in debt which has lost millions of dollars every quarter for nearly seven years. What new technology, systems, or market niche does this company have to offer? Perhaps there are investors more pretentious and ignorant than the current management and investors.